Broder Joshua, Jerrard David, Olshaker Jonathan, Witting Michael
Division of Emergency Medicine, University of Maryland Department of Surgery, Baltimore, Maryland, USA.
Am J Emerg Med. 2004 Jan;22(1):10-3. doi: 10.1016/j.ajem.2003.09.004.
To assess the need for antibiotics in low-risk human bite wounds, a prospective, double-blind, placebo-controlled study involving 127 patients presenting with low-risk human bite wounds over 2 years to a 40,000 visit per year major academic ED was performed. Low-risk bites penetrated only the epidermis and did not involve hands, feet, skin, overlying joints, or cartilaginous structures. Exclusion criteria included age less than 18 years, puncture wounds, immunocompromise, allergy to penicillin or related compound, or bites greater than 24 hours old. Patients were randomly assigned to receive either a cephalexin/penicillin combination or placebo. One hundred twenty-five patients completed the study. Infection developed in 1 of 62 patients receiving placebo (1.6%, 95% confidence interval CI, 0-7.3%). Infection developed in 0 of 63 patients receiving the cephalexin/penicillin combination (0%, 95% CI, 0-4.6%). Antibiotic treatment of some low-risk human bite wound could be unnecessary. Infection rates appear similar in low-risk human bite wounds whether treated with antibiotics or placebo.
为评估低风险人类咬伤伤口使用抗生素的必要性,我们进行了一项前瞻性、双盲、安慰剂对照研究,该研究纳入了在两年内到一所每年接诊量达40000人次的大型学术急诊部就诊的127例低风险人类咬伤伤口患者。低风险咬伤仅穿透表皮,且不涉及手、足、皮肤、覆盖的关节或软骨结构。排除标准包括年龄小于18岁、穿刺伤、免疫功能低下、对青霉素或相关化合物过敏,或咬伤时间超过24小时。患者被随机分配接受头孢氨苄/青霉素组合或安慰剂治疗。125例患者完成了研究。接受安慰剂治疗的62例患者中有1例发生感染(1.6%,95%置信区间CI,0 - 7.3%)。接受头孢氨苄/青霉素组合治疗的63例患者中无一例发生感染(0%,95%CI,0 - 4.6%)。对一些低风险人类咬伤伤口进行抗生素治疗可能是不必要的。无论用抗生素还是安慰剂治疗,低风险人类咬伤伤口的感染率似乎相似。